Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B
- PMID: 20536558
- DOI: 10.1111/j.0105-2896.2010.00908.x
Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B
Abstract
The caspase family of cysteine proteases becomes activated in response to diverse cellular insults and coordinates apoptosis through proteolysis of hundreds of cellular substrates. Cytotoxic lymphocytes are adept at promoting apoptosis of virally infected or transformed cells through delivery of cytotoxic enzymes, such as granzyme B, into target cells via the granule exocytosis pathway. Granzyme B promotes apoptosis of target cells through direct processing of certain caspases, which leads to their autoactivation. Granzyme B can also activate caspases indirectly through proteolysis of Bid, a protein that promotes mitochondrial permeabilization and consequent activation of the apoptosome pathway to caspase activation. Evidence also indicates that granzyme B may contribute to antiviral immunity by directly suppressing viral replication through direct proteolysis of viral proteins that are essential for pathogenicity. Recent reports also suggest that granzyme B may have additional non-cytotoxic roles under certain circumstances and may also function in the extracellular space. Here, we discuss the cytotoxic and putative non-cytotoxic functions of granzyme B within the immune system.
Similar articles
-
Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.Immunol Rev. 2010 May;235(1):128-46. doi: 10.1111/j.0105-2896.2010.00909.x. Immunol Rev. 2010. PMID: 20536560 Review.
-
Orphan granzymes find a home.Immunol Rev. 2010 May;235(1):117-27. doi: 10.1111/j.0105-2896.2010.00889.x. Immunol Rev. 2010. PMID: 20536559 Review.
-
Human and murine granzyme B exhibit divergent substrate preferences.J Cell Biol. 2007 Feb 12;176(4):435-44. doi: 10.1083/jcb.200612025. Epub 2007 Feb 5. J Cell Biol. 2007. PMID: 17283187 Free PMC article.
-
Mechanisms of granule-dependent killing.Cell Death Differ. 2008 Feb;15(2):251-62. doi: 10.1038/sj.cdd.4402244. Epub 2007 Nov 2. Cell Death Differ. 2008. PMID: 17975553 Review.
-
Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.Biochem J. 2010 Nov 1;431(3):423-31. doi: 10.1042/BJ20091073. Biochem J. 2010. PMID: 20704564
Cited by
-
The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue.PLoS One. 2012;7(4):e33899. doi: 10.1371/journal.pone.0033899. Epub 2012 Apr 3. PLoS One. 2012. PMID: 22509265 Free PMC article.
-
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.Cancers (Basel). 2022 May 25;14(11):2603. doi: 10.3390/cancers14112603. Cancers (Basel). 2022. PMID: 35681583 Free PMC article. Review.
-
CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.Clin Exp Immunol. 2025 Jan 21;219(1):uxae095. doi: 10.1093/cei/uxae095. Clin Exp Immunol. 2025. PMID: 39432677
-
TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3392-401. doi: 10.1073/pnas.1500857112. Epub 2015 Jun 8. Proc Natl Acad Sci U S A. 2015. PMID: 26056259 Free PMC article.
-
Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.J Clin Invest. 2018 Aug 1;128(8):3460-3474. doi: 10.1172/JCI120555. Epub 2018 Jul 16. J Clin Invest. 2018. PMID: 29851415 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources